Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Glucotrack, Inc.

Glucotrack Appoints Neuromodulation and Painful Diabetic Neuropathy Expert, Usman Latif, MD, MBA, to Clinical Advisory Team
From Glucotrack, Inc.
Via GlobeNewswire
Tickers GCTK
Glucotrack, Inc. Reminds Shareholders to Vote
From Glucotrack, Inc.
Via GlobeNewswire
Tickers GCTK
Glucotrack to Participate in the Q3 Virtual Investor Summit
From Glucotrack, Inc.
Via GlobeNewswire
Tickers GCTK
Glucotrack Expands Clinical Advisory Team Appointing David S. Hirsh, MD as Medical Director, Cardiology
From Glucotrack, Inc.
Via GlobeNewswire
Tickers GCTK
Glucotrack to Exhibit at 2025 Association of Diabetes Care and Education Specialists Annual Meeting
From Glucotrack, Inc.
Via GlobeNewswire
Tickers GCTK
Glucotrack Announces Repurchase of Series A Warrants
From Glucotrack, Inc.
Via GlobeNewswire
Tickers GCTK
Glucotrack and OneTwo Analytics Present Positive Final Results of First-In-Human Study for Continuous Blood Glucose Monitor at American Diabetes Association’s 85th Scientific Sessions
From Glucotrack, Inc.
Via GlobeNewswire
Tickers GCTK
Glucotrack to Showcase Long-Term Continuous Blood Glucose Monitor at American Diabetes Association’s 85th Scientific Sessions
From Glucotrack, Inc.
Via GlobeNewswire
Tickers GCTK
Glucotrack Strengthens Board of Directors with Election of Victoria E. Carr-Brendel, PhD
From Glucotrack, Inc.
Via GlobeNewswire
Tickers GCTK RBOT
Glucotrack Establishes Patient Advisory Board to Inform Diabetes Technology Development
From Glucotrack, Inc.
Via GlobeNewswire
Tickers GCTK
Glucotrack Announces Ethical Approval for Long-Term Clinical Study of Continuous Blood Glucose Monitor
From Glucotrack, Inc.
Via GlobeNewswire
Tickers GCTK
Glucotrack to Participate in FORGETDIABETES, a Prominent European Research Initiative to Develop a Bionic Pancreas
From Glucotrack, Inc.
Via GlobeNewswire
Tickers GCTK
Glucotrack and OneTwo Analytics to Collaborate for Clinical Study Analysis on Its Continuous Blood Glucose Monitor
From Glucotrack, Inc.
Via GlobeNewswire
Tickers GCTK
Glucotrack to Present First-In-Human Study Results for Continuous Blood Glucose Monitor at the 2025 International Conference on Advanced Technologies & Treatment for Diabetes
From Glucotrack, Inc.
Via GlobeNewswire
Tickers GCTK
Glucotrack Appoints Guillermo Umpierrez, MD, CDCES, FACE, MACP as New Medical Advisory Board Member
From Glucotrack, Inc.
Via GlobeNewswire
Tickers GCTK
Glucotrack Announces Successful Completion of Its First Human Clinical Study of Continuous Blood Glucose Monitor
From Glucotrack, Inc.
Via GlobeNewswire
Tickers GCTK
Glucotrack Announces Reverse Stock Split
From Glucotrack, Inc.
Via GlobeNewswire
Tickers GCTK
Glucotrack Strengthens Leadership Team with Appointment of New Chief Financial Officer
From Glucotrack, Inc.
Via GlobeNewswire
Tickers GCTK
Glucotrack Announces ISO 13485:2016 Certification
From Glucotrack, Inc.
Via GlobeNewswire
Tickers GCTK
Glucotrack Strenghtens Leadership Team with Addition of Industry Veteran as Vice President of Regulatory Affairs
From Glucotrack, Inc.
Via GlobeNewswire
Tickers GCTK
Glucotrack to Present at TechBio Showcase™ 2025
From Glucotrack, Inc.
Via GlobeNewswire
Tickers GCTK
GLUCOTRACK ANNOUNCES THE HIRING OF DR. MARK TAPSAK
From GlucoTrack, Inc.
Via GlobeNewswire
Tickers GCTK
GLUCOTRACK TO BEGIN RESEARCH & DEVELOPMENT OF NOVEL CONTINUOUS GLUCOSE MONITORING SYSTEM
From GlucoTrack, Inc.
Via GlobeNewswire
Tickers GCTK
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.